Transmembrane Helices 7 and 8 Confer Aggregation Sensitivity to the Cystic Fibrosis Transmembrane Conductance Regulator

The Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) is a large multi-spanning membrane protein that is susceptible to misfolding and aggregation. We have identified here the region responsible for this instability. Temperature-induced aggregation of C-terminally truncated versions of CFTR demonstrated that all truncations up to the second transmembrane domain (TMD2), including the R region, largely resisted aggregation. Limited proteolysis identified a folded structure that was prone to aggregation and consisted of TMD2 and at least part of the Regulatory Region R. Only when both TM7 (TransMembrane helix 7) and TM8 were present, TMD2 fragments became as aggregation-sensitive as wild-type CFTR, in line with increased thermo-instability of late CFTR nascent chains and in silico prediction of aggregation propensity. In accord, isolated TMD2 was degraded faster in cells than isolated TMD1. We conclude that TMD2 extended at its N-terminus with part of the R region forms a protease-resistant structure that induces heat instability in CFTR and may be responsible for its limited intracellular stability.

[1]  G. Tartaglia,et al.  A Computational Approach Reveals the Ability of Amyloids to Sequester RNA: the Alpha Synuclein Case , 2023, bioRxiv.

[2]  M. Niemi,et al.  Novel inhibitors of breast cancer resistance protein (BCRP, ABCG2) among marketed drugs. , 2022, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[3]  D. Hebert,et al.  Calnexin reveals a sugar‐free taste within the lipid bilayer , 2022, The EMBO journal.

[4]  R. Hegde,et al.  Substrate-driven assembly of a translocon for multipass membrane proteins , 2022, Nature.

[5]  R. Hegde,et al.  Mechanism of an intramembrane chaperone for multipass membrane proteins , 2022, Nature.

[6]  J. Mornon,et al.  Digging into the 3D Structure Predictions of AlphaFold2 with Low Confidence: Disorder and Beyond , 2022, Biomolecules.

[7]  P. van der Sluijs,et al.  Redefining Hypo- and Hyper-Responding Phenotypes of CFTR Mutants for Understanding and Therapy , 2022, bioRxiv.

[8]  E. Park,et al.  Mechanism of Protein Translocation by the Sec61 Translocon Complex. , 2022, Cold Spring Harbor perspectives in biology.

[9]  P. van der Sluijs,et al.  ABC-transporter CFTR folds with high fidelity through a modular, stepwise pathway , 2022, bioRxiv.

[10]  Matthias J. Feige,et al.  Intramembrane client recognition potentiates the chaperone functions of calnexin , 2022, bioRxiv.

[11]  M. Reichelt,et al.  A membrane protein display platform for receptor interactome discovery , 2021, Proceedings of the National Academy of Sciences.

[12]  R. Pappu,et al.  AlphaFold and implications for intrinsically disordered proteins. , 2021, Journal of molecular biology.

[13]  Oriol Vinyals,et al.  Highly accurate protein structure prediction with AlphaFold , 2021, Nature.

[14]  A. Pastore,et al.  Aggregation is a Context-Dependent Constraint on Protein Evolution , 2021, bioRxiv.

[15]  S. Randell,et al.  DNAJB12 and Hsp70 triage arrested intermediates of N1303K-CFTR for endoplasmic reticulum-associated autophagy , 2021, Molecular biology of the cell.

[16]  P. van der Sluijs,et al.  Co-translational folding of the first transmembrane domain of ABC-transporter CFTR is supported by assembly with the first cytosolic domain , 2020, bioRxiv.

[17]  Conrad C. Huang,et al.  UCSF ChimeraX: Structure visualization for researchers, educators, and developers , 2020, Protein science : a publication of the Protein Society.

[18]  A. Burlingame,et al.  An ER translocon for multi-pass membrane protein biogenesis , 2020, eLife.

[19]  I. Callebaut,et al.  Functional rescue of an ABCB11 mutant by ivacaftor: A new targeted pharmacotherapy approach in bile salt export pump deficiency , 2020, Liver international : official journal of the International Association for the Study of the Liver.

[20]  A. Aksimentiev,et al.  Protein unfolding by SDS: the microscopic mechanisms and the properties of the SDS-protein assembly. , 2020, Nanoscale.

[21]  P. Picotti,et al.  Mass spectrometry analysis of the structural proteome. , 2019, Current opinion in structural biology.

[22]  B. Shoichet,et al.  Structural identification of a hotspot on CFTR for potentiation , 2019, Science.

[23]  X. Zou,et al.  Identifying the molecular target sites for CFTR potentiators GLPG1837 and VX-770 , 2019, The Journal of general physiology.

[24]  P. van der Sluijs,et al.  Characterization of CNPY5 and its family members , 2019, Protein science : a publication of the Protein Society.

[25]  P. Linsdell,et al.  Contribution of the eighth transmembrane segment to the function of the CFTR chloride channel pore , 2019, Cellular and Molecular Life Sciences.

[26]  C. Sanders,et al.  Folding and Misfolding of Human Membrane Proteins in Health and Disease: From Single Molecules to Cellular Proteostasis , 2019, Chemical reviews.

[27]  Jue Chen,et al.  Molecular structure of the ATP-bound, phosphorylated human CFTR , 2018, Proceedings of the National Academy of Sciences.

[28]  R. Hegde,et al.  EMC Is Required to Initiate Accurate Membrane Protein Topogenesis , 2018, Cell.

[29]  J. Riordan,et al.  Cryo-EM visualization of an active high open probability CFTR ion channel , 2018, bioRxiv.

[30]  K. Conrath,et al.  A common mechanism for CFTR potentiators , 2017, The Journal of general physiology.

[31]  D. Tieleman,et al.  Structure of Transmembrane Helix 8 and Possible Membrane Defects in CFTR , 2017, bioRxiv.

[32]  J. Riordan,et al.  Stabilization of a nucleotide-binding domain of the cystic fibrosis transmembrane conductance regulator yields insight into disease-causing mutations , 2017, The Journal of Biological Chemistry.

[33]  C. Dobson,et al.  Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade. , 2017, Annual review of biochemistry.

[34]  D. Gadsby,et al.  Molecular Structure of the Human CFTR Ion Channel , 2017, Cell.

[35]  I. Callebaut,et al.  Functional defect of variants in the adenosine triphosphate–binding sites of ABCB4 and their rescue by the cystic fibrosis transmembrane conductance regulator potentiator, ivacaftor (VX‐770) , 2017, Hepatology.

[36]  Tudor I. Oprea,et al.  A comprehensive map of molecular drug targets , 2016, Nature Reviews Drug Discovery.

[37]  Jue Chen,et al.  Atomic Structure of the Cystic Fibrosis Transmembrane Conductance Regulator , 2016, Cell.

[38]  J. Weissman,et al.  The SND proteins constitute an alternative targeting route to the endoplasmic reticulum , 2016, Nature.

[39]  R. Ford,et al.  The cystic fibrosis transmembrane conductance regulator (CFTR) and its stability , 2016, Cellular and Molecular Life Sciences.

[40]  Ya-xin Lou,et al.  MARCH2 regulates autophagy by promoting CFTR ubiquitination and degradation and PIK3CA-AKT-MTOR signaling , 2016, Autophagy.

[41]  J. Riordan,et al.  Thermal stability of purified and reconstituted CFTR in a locked open channel conformation. , 2015, Protein expression and purification.

[42]  L. DeLucas,et al.  A survey of detergents for the purification of stable, active human cystic fibrosis transmembrane conductance regulator (CFTR). , 2014, Biochimica et biophysica acta.

[43]  J. Forman-Kay,et al.  Regulatory R region of the CFTR chloride channel is a dynamic integrator of phospho-dependent intra- and intermolecular interactions , 2013, Proceedings of the National Academy of Sciences.

[44]  D. Clarke,et al.  Corrector VX-809 stabilizes the first transmembrane domain of CFTR. , 2013, Biochemical pharmacology.

[45]  D. Duan,et al.  Regulation of Activation and Processing of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) by a Complex Electrostatic Interaction between the Regulatory Domain and Cytoplasmic Loop 3* , 2012, The Journal of Biological Chemistry.

[46]  D. Clarke,et al.  Corrector-mediated rescue of misprocessed CFTR mutants can be reduced by the P-glycoprotein drug pump. , 2012, Biochemical pharmacology.

[47]  K. Du,et al.  Correction of Both NBD1 Energetics and Domain Interface Is Required to Restore ΔF508 CFTR Folding and Function , 2012, Cell.

[48]  Philip J. Thomas,et al.  Requirements for Efficient Correction of ΔF508 CFTR Revealed by Analyses of Evolved Sequences , 2012, Cell.

[49]  Philip J. Thomas,et al.  The Primary Folding Defect and Rescue of ΔF508 CFTR Emerge during Translation of the Mutant Domain , 2010, PloS one.

[50]  Julie D Forman-Kay,et al.  NMR evidence for differential phosphorylation‐dependent interactions in WT and ΔF508 CFTR , 2010, The EMBO journal.

[51]  J. Riordan,et al.  Architecture of the cystic fibrosis transmembrane conductance regulator protein and structural changes associated with phosphorylation and nucleotide binding. , 2009, Journal of structural biology.

[52]  G. von Heijne,et al.  Membrane-integration characteristics of two ABC transporters, CFTR and P-glycoprotein. , 2009, Journal of molecular biology.

[53]  G. Lukács,et al.  N-glycans are direct determinants of CFTR folding and stability in secretory and endocytic membrane traffic , 2009, The Journal of cell biology.

[54]  W. Skach,et al.  Sequence-specific retention and regulated integration of a nascent membrane protein by the endoplasmic reticulum Sec61 translocon. , 2008, Molecular biology of the cell.

[55]  A. Evagelidis,et al.  PKC phosphorylation modulates PKA-dependent binding of the R domain to other domains of CFTR. , 2008, American journal of physiology. Cell physiology.

[56]  D. Cyr,et al.  Assembly and misassembly of cystic fibrosis transmembrane conductance regulator: folding defects caused by deletion of F508 occur before and after the calnexin-dependent association of membrane spanning domain (MSD) 1 and MSD2. , 2008, Molecular biology of the cell.

[57]  Blanche Schwappach,et al.  The GET Complex Mediates Insertion of Tail-Anchored Proteins into the ER Membrane , 2008, Cell.

[58]  Michele Vendruscolo,et al.  Prediction of aggregation-prone regions in structured proteins. , 2008, Journal of molecular biology.

[59]  M. Vendruscolo,et al.  The Zyggregator method for predicting protein aggregation propensities. , 2008, Chemical Society reviews.

[60]  B. Wang,et al.  BAP31 Interacts with Sec61 Translocons and Promotes Retrotranslocation of CFTRΔF508 via the Derlin-1 Complex , 2008, Cell.

[61]  J. Riordan,et al.  CFTR function and prospects for therapy. , 2008, Annual review of biochemistry.

[62]  G. Heijne,et al.  Molecular code for transmembrane-helix recognition by the Sec61 translocon , 2007, Nature.

[63]  J. Forman-Kay,et al.  CFTR regulatory region interacts with NBD1 predominantly via multiple transient helices , 2007, Nature Structural &Molecular Biology.

[64]  G. Cutting,et al.  The CFTR-derived peptides as a model of sequence-specific protein aggregation , 2007, Cellular & Molecular Biology Letters.

[65]  Andrei Aleksandrov,et al.  Domain interdependence in the biosynthetic assembly of CFTR. , 2007, Journal of molecular biology.

[66]  I. Braakman,et al.  Folding of CFTR is predominantly cotranslational. , 2005, Molecular cell.

[67]  M. Amaral,et al.  Most F508del-CFTR Is Targeted to Degradation at an Early Folding Checkpoint and Independently of Calnexin , 2005, Molecular and Cellular Biology.

[68]  Dmitrij Frishman,et al.  STRIDE: a web server for secondary structure assignment from known atomic coordinates of proteins , 2004, Nucleic Acids Res..

[69]  J. Wakefield,et al.  Efficient Intracellular Processing of the Endogenous Cystic Fibrosis Transmembrane Conductance Regulator in Epithelial Cell Lines* , 2004, Journal of Biological Chemistry.

[70]  B. Papsin,et al.  Misfolding diverts CFTR from recycling to degradation , 2004, The Journal of cell biology.

[71]  Christopher M Dobson,et al.  Principles of protein folding, misfolding and aggregation. , 2004, Seminars in cell & developmental biology.

[72]  S. Dhani,et al.  Stable dimeric assembly of the second membrane-spanning domain of CFTR (cystic fibrosis transmembrane conductance regulator) reconstitutes a chloride-selective pore. , 2003, The Biochemical journal.

[73]  H. Hauri,et al.  A high-molecular-weight complex of membrane proteins BAP29/BAP31 is involved in the retention of membrane-bound IgD in the endoplasmic reticulum , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[74]  S. High,et al.  Role of calnexin in the glycan‐independent quality control of proteolipid protein , 2003, The EMBO journal.

[75]  D. Thirumalai,et al.  Emerging ideas on the molecular basis of protein and peptide aggregation. , 2003, Current opinion in structural biology.

[76]  W. Skach,et al.  Cooperativity and Flexibility of Cystic Fibrosis Transmembrane Conductance Regulator Transmembrane Segments Participate in Membrane Localization of a Charged Residue* , 2002, The Journal of Biological Chemistry.

[77]  L. Berthiaume,et al.  Properties of the Na+/H+ exchanger protein. Detergent-resistant aggregation and membrane microdistribution. , 2002, European journal of biochemistry.

[78]  G. Cutting,et al.  Aggregation of Misfolded Proteins Can Be a Selective Process Dependent upon Peptide Composition* , 2002, The Journal of Biological Chemistry.

[79]  A. Helenius,et al.  ER quality control: towards an understanding at the molecular level. , 2001, Current opinion in cell biology.

[80]  M. Reth,et al.  Control of Cystic Fibrosis Transmembrane Conductance Regulator Expression by BAP31* , 2001, The Journal of Biological Chemistry.

[81]  P. Cresswell,et al.  Quality control of transmembrane domain assembly in the tetraspanin CD82 , 2001, The EMBO journal.

[82]  G. Lukács,et al.  Conformational and Temperature-sensitive Stability Defects of the ΔF508 Cystic Fibrosis Transmembrane Conductance Regulator in Post-endoplasmic Reticulum Compartments* , 2001, The Journal of Biological Chemistry.

[83]  G. Cutting,et al.  A PDZ-binding motif is essential but not sufficient to localize the C terminus of CFTR to the apical membrane. , 2001, Journal of cell science.

[84]  Ming-Ming Zhou Phosphothreonine recognition comes into focus , 2000, Nature Structural Biology.

[85]  H. Perreault,et al.  Secondary structure and oligomerization of the E. coli glycerol facilitator. , 2000, Biochemistry.

[86]  I. Braakman,et al.  The CXXCXXC motif determines the folding, structure and stability of human Ero1‐Lα , 2000, The EMBO journal.

[87]  King Sa,et al.  R-domain interactions with distal regions of CFTR lead to phosphorylation and activation. , 2000 .

[88]  Michele C. Kieke,et al.  Directed evolution of a stable scaffold for T-cell receptor engineering , 2000, Nature Biotechnology.

[89]  A. D. Robertson,et al.  A functional R domain from cystic fibrosis transmembrane conductance regulator is predominantly unstructured in solution. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[90]  William F. DeGrado,et al.  Asparagine-mediated self-association of a model transmembrane helix , 2000, Nature Structural Biology.

[91]  F. Hartl,et al.  An unstable transmembrane segment in the cystic fibrosis transmembrane conductance regulator , 1999, The EMBO journal.

[92]  J. Blalock,et al.  CFTR chloride channel regulation by an interdomain interaction. , 1999, Science.

[93]  K D Wittrup,et al.  Yeast polypeptide fusion surface display levels predict thermal stability and soluble secretion efficiency. , 1999, Journal of molecular biology.

[94]  Min Goo Lee,et al.  Dynamic Association of Proteasomal Machinery with the Centrosome , 1999, The Journal of cell biology.

[95]  D. Cyr,et al.  The Hdj‐2/Hsc70 chaperone pair facilitates early steps in CFTR biogenesis , 1999, The EMBO journal.

[96]  R. Kopito,et al.  Aggresomes: A Cellular Response to Misfolded Proteins , 1998, The Journal of cell biology.

[97]  P. Sluijs,et al.  An aquaporin-2 water channel mutant which causes autosomal dominant nephrogenic diabetes insipidus is retained in the Golgi complex. , 1998, The Journal of clinical investigation.

[98]  G. Lukács,et al.  Limited proteolysis as a probe for arrested conformational maturation of ΔF508 CFTR , 1998, Nature Structural Biology.

[99]  S. Hubbard,et al.  The structural aspects of limited proteolysis of native proteins. , 1998, Biochimica et biophysica acta.

[100]  J. Widdicombe,et al.  Structural cues involved in endoplasmic reticulum degradation of G85E and G91R mutant cystic fibrosis transmembrane conductance regulator. , 1997, The Journal of clinical investigation.

[101]  M. Welsh,et al.  Association of domains within the cystic fibrosis transmembrane conductance regulator. , 1997, Biochemistry.

[102]  J. Henry,et al.  SDS-resistant aggregation of membrane proteins: application to the purification of the vesicular monoamine transporter. , 1996, The Biochemical journal.

[103]  Satoshi Omura,et al.  Degradation of CFTR by the ubiquitin-proteasome pathway , 1995, Cell.

[104]  J. Riordan,et al.  Multiple proteolytic systems, including the proteasome, contribute to CFTR processing , 1995, Cell.

[105]  S. High,et al.  The translocation, folding, assembly and redox-dependent degradation of secretory and membrane proteins in semi-permeabilized mammalian cells. , 1995, The Biochemical journal.

[106]  J. Riordan,et al.  Participation of the endoplasmic reticulum chaperone calnexin (p88, IP90) in the biogenesis of the cystic fibrosis transmembrane conductance regulator. , 1994, The Journal of biological chemistry.

[107]  M. Welsh,et al.  The amino-terminal portion of CFTR forms a regulated CI− channel , 1994, Cell.

[108]  P. Greengard,et al.  Phosphorylation of the cystic fibrosis transmembrane conductance regulator. , 1992, The Journal of biological chemistry.

[109]  H. Hobbs,et al.  The LDL receptor locus in familial hypercholesterolemia: mutational analysis of a membrane protein. , 1990, Annual review of genetics.

[110]  L. Tsui,et al.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. , 1989, Science.

[111]  R. Doolittle,et al.  A simple method for displaying the hydropathic character of a protein. , 1982, Journal of molecular biology.

[112]  C. Tanford,et al.  Characterization of membrane proteins in detergent solutions. , 1976, Biochimica et biophysica acta.

[113]  Kai Du,et al.  The ΔF508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR , 2005, Nature Structural &Molecular Biology.

[114]  J. Riordan,et al.  A novel CFTR disease-associated mutation causes addition of an extra N-linked oligosaccharide , 2004, Glycoconjugate Journal.

[115]  P. Picotti,et al.  Probing protein structure by limited proteolysis. , 2004, Acta biochimica Polonica.

[116]  D. Engelman,et al.  Helical membrane protein folding, stability, and evolution. , 2000, Annual review of biochemistry.

[117]  W. Wimley,et al.  Membrane protein folding and stability: physical principles. , 1999, Annual review of biophysics and biomolecular structure.

[118]  J. Riordan Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA , 1989 .